Molecular Vaccines -

Molecular Vaccines

From Prophylaxis to Therapy - Volume 2

Matthias Giese (Herausgeber)

Buch | Hardcover
XXVIII, 423 Seiten
2013 | 2014
Springer International Publishing (Verlag)
978-3-319-00977-3 (ISBN)
213,99 inkl. MwSt
This book examines all aspects of global molecular vaccine research and development. It describes the development of new vaccines from bench to preclinical to clinical studies and launch to the market under EMA and FDA guidelines.
This title discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

Dr. Matthias Giese, Heidelberg, Germany

Non-infectious and non-cancer vaccines.- Adjuvants and nanotechnology.- In silico and delivery systems.- Patenting, manufacturing, registration.

Erscheint lt. Verlag 20.11.2013
Reihe/Serie Molecular Vaccines
Zusatzinfo XXVIII, 423 p. 98 illus., 74 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 1119 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Studium Querschnittsbereiche Infektiologie / Immunologie
Naturwissenschaften Biologie Genetik / Molekularbiologie
Schlagworte cell vaccines • Delivery systems • prophyalxis and therapy • vaccine adjuvants • vaccines • vaccine tools
ISBN-10 3-319-00977-X / 331900977X
ISBN-13 978-3-319-00977-3 / 9783319009773
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Oliver Schmetzer

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00